US vaccine maker Moderna announced Monday that it would build its first mRNA jab-manufacturing facility in Africa after signing an agreement with Kenya's government to produce up to 500 million doses a year.
The company said it expected to invest $500 million (€460 million) in the new facility, which will produce vaccines for the continent of 1.3 billion people whose population has been largely shut out of access to Covid jabs.
